Introduction of whole genome sequencing as NHS standard of care for glioma patients in two neurosurgical oncology centres: West Midlands
WGS is feasible for patients undergoing biopsy or craniotomy. NHS infrastructural resources and improvement of WGS technologies are required to improve turnaround time and ensure equitable access for all patients with glioma.
Authors
- Victoria Wykes (ORCID: https://orcid.org/0000-0002-2998-8919)
- Yvonne Wallis (ORCID: https://orcid.org/0000-0002-5079-967X)
- Manoj Raghavan (ORCID: https://orcid.org/0000-0002-5464-2602)
- Colin Watts (ORCID: https://orcid.org/0000-0003-3531-8791)
- Vinton W.T. Cheng (ORCID: https://orcid.org/0000-0003-4159-8697)
- Christine Bennett
- Ute Pohl
- Erminia Albanese
- Vassili Crispi (ORCID: https://orcid.org/0000-0002-9141-4297)
- Natasha Vafadar
- Taufiq Khan
- L. Hughes
- Naomi Cole
- Sana Manan
Institutions
- Queen Elizabeth Hospital Birmingham (GB)
- Royal Stoke University Hospital (GB)
- Cancer Research UK Clinical Trials Unit (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- BJC Reports
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1038/s44276-025-00168-9
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00